Showing results (1591-1600 of 2,182) with videos related to
Sort By:
Pageof 219
Journal of Biopharmaceutical Statistics|June 5, 2024
Improved automated spot counting and modeling with bias correctionChun Pang Lin, Yajie Duan, Davit Sargsyan, et al.Journal of Biopharmaceutical Statistics|June 18, 2024
Pharmacometrics-Enabled DOse OPtimization (PEDOOP) for seamless phase I-II trials in oncologyShijie Yuan, Zhanbo Huang, Jiaxin Liu, et al.Journal of Biopharmaceutical Statistics|June 18, 2024
Clustering plasma concentration-time curves: applications of unsupervised learning in pharmacogenomicsJackson P Lautier, Stella Grosser, Jessica Kim, et al.Journal of Biopharmaceutical Statistics|June 18, 2024
A comparison of Bayesian and score methods for interval estimates of positive/negative likelihood ratios in support of diagnostic device performance evaluationTingting Hu, Berkman Sahiner, Nicholas Petrick, et al.Journal of Biopharmaceutical Statistics|December 22, 2025
Change-point detection in Weibull-accelerated failure time models via narrowest significance pursuitMd Hasinur Rahaman Khan, Samia AshrafiJournal of Biopharmaceutical Statistics|November 19, 2025
Blinded sample size re-estimation in a crossover studyShaofei Zhao, Balakrishna Hosmane, Chen Chen, et al.Journal of Biopharmaceutical Statistics|May 5, 2024
Adaptive two-stage seamless sequential design for clinical trialsPing Gao, Yingqiu LiJournal of Biopharmaceutical Statistics|April 30, 2024
[Special issue PRO] A demonstration of estimands and sensitivity analyses for time-to-deterioration of patient reported outcomesLysbeth Floden, Michael DeRosa, Jessica Roydhouse, et al.Journal of Biopharmaceutical Statistics|April 17, 2024
Utility of real-world evidence in biosimilar developmentRamin B Arani, Jessie Wang, Dong Pang, et al.Journal of Biopharmaceutical Statistics|April 14, 2024
Adaptive promising zone design for cancer immunotherapy with heterogeneous delayed treatment effectBosheng Li, Fangrong Yan, Depeng JiangPageof 219